Jan Hansen Selected Research

Jan Hansen Research Topics

4	Insulin Resistance 01/2021 - 12/2016
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 09/2014
1	Ischemia 01/2020
1	Infarction (Infarctions) 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018
1	Reperfusion Injury 01/2018
1	Prediabetic State (Prediabetes) 12/2016
1	Body Weight (Weight, Body) 09/2014
1	Atherosclerosis 09/2014
1	Glaucoma 10/2009
1	Bacteremia 12/2007
1	Neoplasms (Cancer) 12/2007
1	Neutropenia 12/2007
1	Thrombocytopenia (Thrombopenia) 12/2007
1	Hematologic Neoplasms (Hematological Malignancy) 12/2007
1	Disease Progression 09/2002

2	ResveratrolIBA 01/2018 - 12/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	6- cyano- 4- (N- ethylsulfonyl- N- methylamino)- 3- hydroxy- 2,2- dimethylchromaneIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2018
1	Pharmaceutical PreparationsIBA 12/2016
1	Dipeptidyl-Peptidase IV InhibitorsIBA 09/2014
1	Blood Glucose (Blood Sugar)IBA 09/2014
1	EnzymesIBA 09/2014
1	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2014
1	IncretinsIBA 09/2014

3	Therapeutics 01/2018 - 10/2009
1	Drug Therapy (Chemotherapy) 12/2007
1	Critical Care (Surgical Intensive Care) 12/2007
1	Transplantation 09/2002